It should be noted that tumorigenesis in CCRCC follows a trunk-branch evolution [37], in which the trunk mutation (VHL) is responsible for tumorigenesis and sub-clonal mutations (i.e., PBRM1, SETD2, BAP1) are developed during disease progression. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.